Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03237689 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Glucocorticoids on Cognition in HIV-infected Women
A Early Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 136
- Enrollment target
NCT03237689: Completed Early Phase 1 study, sponsored by Johns Hopkins University.
NCT03237689 is a Early Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03237689, a Early Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 136 participants
- Enrollment target
Study Summary
Despite treatment with antiretroviral therapy, women living with HIV continue to experience cognitive impairment. Psychological risk factors, including stress, impair cognition more in HIV-infected women than HIV-uninfected women. This study plans to examine a novel intervention for cognitive dysfunction that targets the mechanisms by which stress negatively affects cognitive functioning.
Interventions
- DRUG Hydrocortisone
- DRUG Placebo Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2017-11-20 |
| Est. Completion | 2023-09-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03237689
The ClinicalTrials.gov registry entry for NCT03237689 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydrocortisone is the first listed.
NCT03237689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03237689 about?
NCT03237689 is a clinical study titled "Effects of Glucocorticoids on Cognition in HIV-infected Women". Despite treatment with antiretroviral therapy, women living with HIV continue to experience cognitive impairment. Psychological risk factors, including stress, impair cognition more in HIV-infected women than HIV-uninfected women. This study plans to examine a novel intervention for cognitive dysfun...
What is the current status of trial NCT03237689?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 136 participants. The study started on 2017-11-20. Estimated completion is 2023-09-08.
What interventions are being tested in trial NCT03237689?
The interventions under investigation include: Hydrocortisone (DRUG), Placebo Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT03237689?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.